Showing 2,261 - 2,270 results of 2,270 for search '(( algorithm python function ) OR ((( algorithm within function ) OR ( algorithm fc function ))))', query time: 0.53s Refine Results
  1. 2261

    Image_2_A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer.TIF by Yufeng Guo (563481)

    Published 2021
    “…In the MRSB high-risk group, the hazard curve exhibited an initial wide, high peak within 10 months after treatment, whereas some gentle peaks around 2 years were noted. …”
  2. 2262

    Image_3_A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer.TIF by Yufeng Guo (563481)

    Published 2021
    “…In the MRSB high-risk group, the hazard curve exhibited an initial wide, high peak within 10 months after treatment, whereas some gentle peaks around 2 years were noted. …”
  3. 2263

    Data_Sheet_1_A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer.CSV by Yufeng Guo (563481)

    Published 2021
    “…In the MRSB high-risk group, the hazard curve exhibited an initial wide, high peak within 10 months after treatment, whereas some gentle peaks around 2 years were noted. …”
  4. 2264

    Table_1_A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer.XLSX by Yufeng Guo (563481)

    Published 2021
    “…In the MRSB high-risk group, the hazard curve exhibited an initial wide, high peak within 10 months after treatment, whereas some gentle peaks around 2 years were noted. …”
  5. 2265

    Image_4_A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer.TIF by Yufeng Guo (563481)

    Published 2021
    “…In the MRSB high-risk group, the hazard curve exhibited an initial wide, high peak within 10 months after treatment, whereas some gentle peaks around 2 years were noted. …”
  6. 2266

    Data_Sheet_2_A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer.CSV by Yufeng Guo (563481)

    Published 2021
    “…In the MRSB high-risk group, the hazard curve exhibited an initial wide, high peak within 10 months after treatment, whereas some gentle peaks around 2 years were noted. …”
  7. 2267

    DataSheet1_Mitochondrial-related genes as prognostic and metastatic markers in breast cancer: insights from comprehensive analysis and clinical models.docx by Yutong Fang (16621143)

    Published 2024
    “…Moreover, leveraging the GSE102484 dataset, we conducted differential gene expression analysis to identify MRGs related to metastasis, subsequently developing metastasis models via 10 distinct machine-learning algorithms and then selecting the best-performing model. …”
  8. 2268

    Table1_Mitochondrial-related genes as prognostic and metastatic markers in breast cancer: insights from comprehensive analysis and clinical models.xlsx by Yutong Fang (16621143)

    Published 2024
    “…Moreover, leveraging the GSE102484 dataset, we conducted differential gene expression analysis to identify MRGs related to metastasis, subsequently developing metastasis models via 10 distinct machine-learning algorithms and then selecting the best-performing model. …”
  9. 2269

    Table2_YinChen WuLing powder attenuates non-alcoholic steatohepatitis through the inhibition of the SHP2/PI3K/NLRP3 pathway.xlsx by Xingxing Yuan (6615878)

    Published 2024
    “…Through analytic integration with multiple algorithms, PTPN11 (also known as SHP2) emerged as a core target of YCWLP in mitigating NASH. …”
  10. 2270

    Table1_YinChen WuLing powder attenuates non-alcoholic steatohepatitis through the inhibition of the SHP2/PI3K/NLRP3 pathway.pdf by Xingxing Yuan (6615878)

    Published 2024
    “…Through analytic integration with multiple algorithms, PTPN11 (also known as SHP2) emerged as a core target of YCWLP in mitigating NASH. …”